Exchange: NASDAQ·Updated 04:10 PM EST

About BCDA

About

BioCardia, Inc. is a clinical-stage biotherapeutic company, which engages in the business of developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its pipeline includes CardiAMP, CardiALLO, PulmALLO, Helix Biotherapeutic Delivery System, and Morph DNA and AVANCE Steerable Introducers. The company was founded on January 12, 1994 and is headquartered in Sunnyvale, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
17

Frequently Asked Questions

Advertisement|Remove ads.